AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame rare blood disorder when other treatments fail
Disease control Recruiting nowThis study tests a daily pill called orelabrutinib for people with autoimmune hemolytic anemia (AIHA) that hasn't responded to standard treatments. AIHA is a condition where the immune system mistakenly attacks red blood cells, causing fatigue and anemia. The trial will enroll 50…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental mRNA CAR-T therapy targets autoimmune diseases in first human trial
Disease control Recruiting nowThis early-phase trial tests Arnovie101, an mRNA-based CAR-T therapy given directly into the bloodstream, in 5 people with lupus or autoimmune hemolytic anemia. The goal is to see if it is safe and how the body processes it. Researchers will also check if it reduces disease activ…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: EARLY_PHASE1 • Sponsor: Circunited BioPharma (Shenzhen) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Experimental cell therapy targets tough blood cancers and anemia
Disease control Recruiting nowThis early-phase study is testing a new cell therapy called GT801 in 28 adults with relapsed or hard-to-treat B-cell blood cancers (like leukemia and lymphoma) or autoimmune hemolytic anemia (AIHA). The therapy uses a patient's own immune cells, modified to attack CD19-positive c…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Thousands with blood diseases to be tracked in massive chinese registry
Knowledge-focused Recruiting nowThis study is creating a large database of people in China with various blood diseases, such as leukemia, multiple myeloma, and hemophilia. Researchers will collect information from medical records and follow participants over time to learn about disease patterns, treatments, and…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC